Pulmonary Vascular Pathology in Covid-19. Reply.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Transpulmonary bubble transit in patients hospitalised with COVID-19 pneumonia.BMJ open respiratory research · 2025
   Article
2. The modes of angiogenesis: an updated perspective.Angiogenesis · 2023
   Article
3. Pathological angiogenesis: mechanisms and therapeutic strategies.Angiogenesis · 2023
   Review
4. Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature.Cardiovascular research · 2022
   Article
5. The rising impact of angiogenesis research.Angiogenesis · 2022
   Article
6. Endothelialitis, Microischemia, and Intussusceptive Angiogenesis in COVID-19.Cold Spring Harbor perspectives in medicine · 2022
   Review
7. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Virchows Archiv : an international journal of pathology · 2022
   Review
8. Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation.American journal of clinical pathology · 2022
   Article
9. In Situ Pulmonary Thrombolysis and Perfusion Lung Angiography in Severe COVID-19 Respiratory Failure.Critical care explorations · 2022
   Article
10. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.Angiogenesis · 2021
    Review
11. Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis.Clinical imaging · 2021
    Article
12. Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain.Communications biology · 2021
    Article
13. Best practices for correctly identifying coronavirus by transmission electron microscopy.Kidney international · 2021
    Review
14. The Natural History of a Patient With COVID-19 Pneumonia and Silent Hypoxemia.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2021
    Article
15. [COVID-19: effects on the lungs and heart].Der Pathologe · 2021
    Review
16. Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues.Histopathology · 2021
    Review
17. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Review
18. Derivation and Validation of Clinical Prediction Rules for COVID-19 Mortality in Ontario, Canada.Open forum infectious diseases · 2020
    Article
19. Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow.The European respiratory journal · 2020
    Article

Corrections and comments

• Comment on
  Pulmonary Vascular Pathology in Covid-19.2020
• Comment on
  Pulmonary Vascular Pathology in Covid-19.2020
• Comment on
  Pulmonary Vascular Pathology in Covid-19.2020

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as